ProtoSynth
ProtoSynth is an open-source simulation-first generative AI platform for biomedical research.
Abstract
ProtoSynth is a specialized simulation-first generative AI platform designed to bridge the semantic gap between clinical research intent and technical data analysis. Traditional biomedical analysis often faces two primary hurdles: the syntax gap for non-expert researchers and the privacy bottleneck created by strict data-protection requirements. ProtoSynth addresses these challenges through a grounded, protocol-anchored architecture.
By using retrieval-augmented generation and chain-of-thought reasoning, the platform grounds its generative engine in three user-provided documents: a metadata schema, a physiological data dictionary, and a Statistical Analysis Plan (SAP). It operates in a secure synthetic sandbox, where conditional generative adversarial models simulate high-fidelity tabular data from metadata. Users can then build and validate analysis pipelines in R and Python without touching real patient records.
This train-on-synthesized, test-on-real approach supports robust, reproducible, and auditable code development and aligns with transparent reporting standards. ProtoSynth shifts the role of the researcher from coder to compiler of intent while preserving methodological rigor and privacy-by-design principles.
Rationale
The rationale for ProtoSynth is centered on three practical needs in modern biomedical analytics.
- Trust through grounding: many AI tools suggest methods from generic web patterns rather than study-specific protocol logic. ProtoSynth anchors generation to the SAP and related protocol artifacts to reduce misalignment and hallucinated analysis paths.
- Privacy-by-design: data-access delays and ethics constraints frequently slow early analytics work. ProtoSynth separates logic development from sensitive data access by enabling full pipeline development in a metadata-driven synthetic environment.
- Democratization with methodological focus: domain experts and trainees are often blocked by programming syntax, while biostatisticians are overloaded with boilerplate coding. ProtoSynth lowers the coding barrier for non-programmers and allows expert biostatisticians to focus on design validity, inference quality, and reproducibility.
Personal Statement
My commitment to ProtoSynth is driven by the belief that the future of medicine lies at the intersection of human clinical intuition and algorithmic precision. I approach AI as a compiler of human intent, not an autonomous decision-maker. In this framework, the syntax of R or Python should not be a gatekeeper to high-quality clinical insight.
For me, responsible AI in health research is not only regulatory compliance; it is also provenance, transparency, and fidelity to the original research plan. A synthetic-first workflow is therefore both a technical and ethical choice: it protects patient privacy while building a durable learning environment for researchers. ProtoSynth is intended as a practical movement toward more transparent, accessible, and trustworthy biomedical data science.